Is the practice of using oversized organs for recipients with elevated pulmonary vascular resistance justified?
Karthik Thangappan(Cincinnati Children's Hospital Medical Center), David L.S. Morales(Cincinnati Children's Hospital Medical Center), Farhan Zafar(Cincinnati Children's Hospital Medical Center), Jason W. Greenberg(Cincinnati Children's Hospital Medical Center), David G. Lehenbauer(Cincinnati Children's Hospital Medical Center), Clifford Chin(Cincinnati Children's Hospital Medical Center), Hosam F. Ahmed(Cincinnati Children's Hospital Medical Center), Russel Hirsch(National Heart Institute), Awais Ashfaq(Cincinnati Children's Hospital Medical Center), Alan O’Donnell(Cincinnati Children's Hospital Medical Center)
Cited by 3
Related Papers
Hypoplastic Left Heart Syndrome
|Journal of the American College of Cardiology|2011|498
Prevalence, Morbidity, and Mortality of Heart Failure–Related Hospitalizations in Children in the United States: A Population-Based Study
|Journal of Cardiac Failure|2012|301
Pediatric heart transplant waiting list mortality in the era of ventricular assist devices
|The Journal of Heart and Lung Transplantation|2014|249
Small noncoding differentially methylated copy-number variants, including lncRNA genes, cause a lethal lung developmental disorder
|Genome Research|2012|161
Early experience with the HeartMate 3 continuous-flow ventricular assist device in pediatric patients and patients with congenital heart disease: A multicenter registry analysis
|The Journal of Heart and Lung Transplantation|2020|134